A Case of Neisseria sicca Bacteremia Due to Eculizumab Therapy
Eculizumab is a monoclonal antibody indicated for the treatment of complement-mediated disorders. Despite its utility, eculizumab increases risk for infection with Neisseria species, owing to membrane attack complex inhibition. Although this naturally evokes thought of infection with N meningitidis,...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American College of Physicians
2023-06-01
|
| Edice: | Annals of Internal Medicine: Clinical Cases |
| On-line přístup: | https://www.acpjournals.org/doi/10.7326/aimcc.2022.0934 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|